Contraception · 2014
Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel intrauterine contraception.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kiley Jessica W, Hammond Cassing, Niznik Charlotte, Rademaker Alfred, Liu Dachao, Shulman Lee P
Аннотация
OBJECTIVE: Postpartum contraception is critical in women with gestational diabetes mellitus (GDM). We evaluated the effect of the levonorgestrel intrauterine system (LNG-IUS) on glucose tolerance in postpartum women with GDM.
STUDY DESIGN: The study is a descriptive analysis of 12-month glucose tolerance in women with recent GDM who used the LNG-IUS, the copper IUD or postpartum sterilization.
RESULTS: Twelve months postpartum, 3 of 13 LNG-IUS users (23.1%) and 1 of 6 nonhormonal contraceptive users (16.6%) had prediabetes. No woman developed overt diabetes.
CONCLUSIONS: This study is the first and only to measure the metabolic effects of the LNG-IUS women with GDM. Larger trials are necessary.
IMPLICATIONS: Use of levonorgestrel intrauterine contraception does not appear to negatively affect glucose tolerance in postpartum women with a history of gestational diabetes. Additional appropriately powered clinical studies are needed to confirm these results.
STUDY DESIGN: The study is a descriptive analysis of 12-month glucose tolerance in women with recent GDM who used the LNG-IUS, the copper IUD or postpartum sterilization.
RESULTS: Twelve months postpartum, 3 of 13 LNG-IUS users (23.1%) and 1 of 6 nonhormonal contraceptive users (16.6%) had prediabetes. No woman developed overt diabetes.
CONCLUSIONS: This study is the first and only to measure the metabolic effects of the LNG-IUS women with GDM. Larger trials are necessary.
IMPLICATIONS: Use of levonorgestrel intrauterine contraception does not appear to negatively affect glucose tolerance in postpartum women with a history of gestational diabetes. Additional appropriately powered clinical studies are needed to confirm these results.
Предметные рубрики MeSH
AdultChicagoContraceptive Agents, FemaleDiabetes, GestationalFemaleFollow-Up StudiesGlucose IntoleranceGlucose Tolerance TestHospitals, UniversityHumansIntrauterine Devices, CopperIntrauterine Devices, MedicatedLevonorgestrelPostpartum PeriodPrediabetic StatePregnancyRiskSterilization, TubalYoung Adult